ClinicalTrials.gg
Status unknownNCT06162637Updated Dec 19, 2023

Femoral Neck Locking Plate Vs Multiple Cannulated Cancellous Screws in Treatment of Femoral Neck Fractures in Young Adults: Randomized Controlled Clinical Trial Study

An interventional study of femoral neck locking plate and multiple cannulated cancellous screws in Femoral Neck Fractures, sponsored by Eslam Mohamed AHmed. Status unknown at 1 site in Egypt. Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-12-19.

Sponsored by Eslam Mohamed AHmed · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2023), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 11 studies in Femoral Neck Fractures with a site in Egypt — 4 open to participants now, 7 under way, none of them phase 3. Femoral Neck Fractures · Egypt.

Planned enrollment
7th of 11
20 · median 30
Started
2024
with 3 others
No phase
10 of 11
4 open now
Registered
4th of 11
by date
Lead sponsor
1 of 11
Eslam Mohamed AHmed

Among the 11 studies in Femoral Neck Fractures with a site in Egypt, this one is the 7th largest by planned enrollment, is one of 4 that started in 2024, is one of 10 with no phase, and was the 4th registered.

Femoral Neck Fractures

207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.

Browse Femoral Neck Fractures studies →

Open to participants now

4 of the 11 studies in Femoral Neck Fractures with a site in Egypt are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 20 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Femoral Neck Fractures with a site in Egypt, or all of them as a file.
02

Study summary

Fracture neck femur are common injuries, especially seen in the elderly in the emergency setting. It is also seen in young patients with high-energy trauma. Immediate diagnosis and management are required to prevent threatening joint complications. Fracture neck femur in young adults is unsolved problem. The preservation of the native hip anatomy and biomechanics is essential in active young adults. Because of the vulnerable blood supply to the femoral part of the hip joint following these fractures, there is a high risk of developing avascular necrosis (AVN) and non-union. Any sort of surgical fixation should aim at preservation the blood supply while securing enough mechanical stability until the fracture unites. Open reduction is indicated in fractures which cannot be anatomically reduced by gentle manipulation. This should be carried out without any delay since this potentially can reduce the incidence of AVN. Treatment of fracture neck femur still controversial. There are several methods for treatment of fracture neck femur as multipe cannulated cancellous screws, locking plate, dynamic hip screw (DHS) with anti-rotational screw, and arthroplasty. There is no internal fixation method superior to another. In this study, we will compare the clinical and radiographic results of femoral neck locking plate vs multiple cannulated cancellous screw in treating femoral neck fractures in young adults.

03

Conditions studied

  • Femoral Neck Fractures
04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients (20-55) years
  • having unilateral traumatic femoral neck fracture
  • idependent walker before trauma without any aids

Exclusion criteria

Exclusion Criteria:

  • open fracture
  • pathological fracture
  • preexisting deformity
  • other pelvic or ipsilateral femoral injuries
  • renal impairment or were on high dose
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    A

    grup A with femoral neck fracture will be fixed by femoral neck locking plate

    Device: femoral neck locking plate

  • Other
    B

    grup B with femoral neck fracture will be fixed by Multiple cannulated cancellous screws

    Device: multiple cannulated cancellous screws

Interventions

  • Devicefemoral neck locking plate

    femoral neck fractures fixation by femoral neck locking plate

  • Devicemultiple cannulated cancellous screws

    femoral neck fractures fixation by multiple cannulated cancellous screws

06

What researchers measure

Primary outcomes

  1. improvement of pain on the Harris Hip Score (HHS) 6 months post operative

    the Harris Hip Score (HHS) is a scale used for evaluating patients following hip fractures. possible scores range for improvement of pain from 44 (no pain) to 0 (totally disabled cripped pain).

    Time frame: 6 months

  2. Clinical evaluation of gait limping on the Harris Hip Score (HHS) 6 months post operative

    the Harris Hip Score (HHS) is a scale used for evaluating patients following hip fractures. possible scores for limping gait range from 11 (none) to 0 (unable to walk).

    Time frame: 6 months

07

Study locations

1 site
  • Sohag university Hospital
    Sohag, Egypt
    • Magdy M Amin, professor · Contact
08

References and documents

Publications

  • Panula J, Pihlajamaki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P, Kivela SL. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord. 2011 May 20;12:105. doi: 10.1186/1471-2474-12-105. PubMed 21599967 ↗
  • Crist BD, Eastman J, Lee MA, Ferguson TA, Finkemeier CG. Femoral Neck Fractures in Young Patients. Instr Course Lect. 2018 Feb 15;67:37-49. PubMed 31411399 ↗
  • Ly TV, Swiontkowski MF. Treatment of femoral neck fractures in young adults. J Bone Joint Surg Am. 2008 Oct;90(10):2254-66. No abstract available. PubMed 18829925 ↗
  • Haidukewych GJ, Rothwell WS, Jacofsky DJ, Torchia ME, Berry DJ. Operative treatment of femoral neck fractures in patients between the ages of fifteen and fifty years. J Bone Joint Surg Am. 2004 Aug;86(8):1711-6. doi: 10.2106/00004623-200408000-00015. PubMed 15292419 ↗
  • Othman YA, Khalefa AH, Ahmed IM, Ahmed KFE. Femoral neck locking plate versus multiple cannulated screws for femoral neck fractures in young adults: a randomized controlled trial. BMC Musculoskelet Disord. 2025 Aug 18;26(1):799. doi: 10.1186/s12891-025-09019-7. PubMed 40826062 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2024; primary completion for Dec 2024, 11 months later.

Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 11 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 68.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2023
First posted
Dec 8, 2023
StartEst.
Jan 1, 2024
Primary completionEst.
Dec 1, 2024
CompletionEst.
Jan 1, 2025
Last update
Dec 19, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06162637
Lead sponsor
Eslam Mohamed AHmed
Responsible party
Eslam Mohamed AHmed (Resident of Orthopaedic department, Sohag University Hospitals, Sohag University) — Sponsor-investigator
First posted
Dec 8, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Dec 1, 2024 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Dec 19, 2023

Study contacts

Islam M Ahmed, resident
Contact
eslammohamed@med.sohag.edu.eg
01094375737
Abdelrahman H Khalifa, professor
Contact
01003701283

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion